These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19896744)

  • 1. Immunochemical binding assays for detection and quantification of trace impurities in biotechnological production.
    Mattiasson B; Teeparuksapun K; Hedström M
    Trends Biotechnol; 2010 Jan; 28(1):20-7. PubMed ID: 19896744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
    Liu DQ; Sun M; Wu L
    Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impurities in drug substances and drug products: new approaches to quantification and qualification.
    Berridge JC
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):7-12. PubMed ID: 8833961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
    Elder DP; Lipczynski AM; Teasdale A
    J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of biosensor-based SPR technology for biological quantification and quality control of pharmaceutical proteins.
    Wang H; Shi J; Wang Y; Cai K; Wang Q; Hou X; Guo W; Zhang F
    J Pharm Biomed Anal; 2009 Dec; 50(5):1026-9. PubMed ID: 19556093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control in combinatorial chemistry: determination of the quantity, purity, and quantitative purity of compounds in combinatorial libraries.
    Yan B; Fang L; Irving M; Zhang S; Boldi AM; Woolard F; Johnson CR; Kshirsagar T; Figliozzi GM; Krueger CA; Collins N
    J Comb Chem; 2003; 5(5):547-59. PubMed ID: 12959555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the investigation and control of process-related impurities in drug substances.
    Argentine MD; Owens PK; Olsen BA
    Adv Drug Deliv Rev; 2007 Jan; 59(1):12-28. PubMed ID: 17189658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of low-level PTFE contamination: An application of solid-state NMR to structure elucidation in the pharmaceutical industry.
    Pham TN; Day CJ; Edwards AJ; Wood HR; Lynch IR; Watson SA; Bretonnet AS; Vogt FG
    J Pharm Biomed Anal; 2011 Jan; 54(2):401-5. PubMed ID: 20880648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in trace analysis of pharmaceutical genotoxic impurities.
    Liu DQ; Sun M; Kord AS
    J Pharm Biomed Anal; 2010 Apr; 51(5):999-1014. PubMed ID: 20022442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.
    Liu DQ; Chen TK; McGuire MA; Kord AS
    J Pharm Biomed Anal; 2009 Sep; 50(2):144-50. PubMed ID: 19427156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tobramycin impurities for quality control process monitoring using high-performance anion-exchange chromatography with integrated pulsed amperometric detection.
    Hanko VP; Rohrer JS; Liu HH; Zheng C; Zhang S; Liu X; Tang X
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):828-33. PubMed ID: 18486398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between HPLC precision and number of significant figures when reporting impurities and when setting specifications.
    Agut C; Segalini A; Bauer M; Boccardi G
    J Pharm Biomed Anal; 2006 May; 41(2):442-8. PubMed ID: 16472956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals.
    Nageswara Rao R; Nagaraju D; Alvi SN; Bhirud SB
    J Pharm Biomed Anal; 2004 Nov; 36(4):759-67. PubMed ID: 15533668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multipurpose capacitive biosensor for assay and quality control of human immunoglobulin G.
    Labib M; Hedström M; Amin M; Mattiasson B
    Biotechnol Bioeng; 2009 Oct; 104(2):312-20. PubMed ID: 19562733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques.
    Hommerson P; Khan AM; Bristow T; Harrison MW; de Jong GJ; Somsen GW
    Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2878-84. PubMed ID: 19670338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central role of chemistry in 'quality by design' approaches to drug development.
    Grewal NK; Leadbeater NE
    Future Med Chem; 2012 Sep; 4(14):1799-810. PubMed ID: 23043477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive phage-based biosensor for the detection of beta-galactosidase.
    Nanduri V; Balasubramanian S; Sista S; Vodyanoy VJ; Simonian AL
    Anal Chim Acta; 2007 Apr; 589(2):166-72. PubMed ID: 17418177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.